Hidetoshi Sumimoto

3.8k total citations · 1 hit paper
55 papers, 3.1k citations indexed

About

Hidetoshi Sumimoto is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Hidetoshi Sumimoto has authored 55 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 25 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in Hidetoshi Sumimoto's work include Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Virus-based gene therapy research (10 papers). Hidetoshi Sumimoto is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Virus-based gene therapy research (10 papers). Hidetoshi Sumimoto collaborates with scholars based in Japan and United States. Hidetoshi Sumimoto's co-authors include Yutaka Kawakami, Tomoko Iwata, Fumie Imabayashi, Robert G. Roeder, Makoto Miyagishi, Hiroyuki Miyoshi, Kazunari Taira, M Horikoshi, Yataro Daigo and S Minakami and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Hidetoshi Sumimoto

54 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

2006 528 citations Hidetoshi Sumimoto, Yutaka Kawakami et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hidetoshi Sumimoto Japan	28	1.7k	1.1k	1.1k	413	253	55	3.1k
Mariam Dohadwala United States	30	1.5k 0.9×	1.3k 1.1×	1.0k 0.9×	628 1.5×	599 2.4×	46	3.9k
Wolfgang Doppler Austria	38	2.1k 1.3×	1.6k 1.4×	987 0.9×	1.0k 2.5×	559 2.2×	90	4.2k
Barbara Majello Italy	32	2.7k 1.6×	557 0.5×	403 0.4×	322 0.8×	408 1.6×	77	3.3k
Suresh Kumar United States	20	1.9k 1.1×	1.2k 1.1×	672 0.6×	182 0.4×	481 1.9×	41	2.9k
Deborah H. Anderson Canada	24	2.8k 1.7×	732 0.6×	641 0.6×	234 0.6×	238 0.9×	59	3.9k
James D. Bretz United States	15	2.6k 1.5×	617 0.5×	1.3k 1.2×	192 0.5×	590 2.3×	24	3.3k
Xavier Graña United States	31	2.8k 1.6×	2.1k 1.9×	358 0.3×	355 0.9×	440 1.7×	63	4.0k
Alexandre Arcaro Switzerland	31	2.6k 1.5×	659 0.6×	761 0.7×	164 0.4×	351 1.4×	51	3.9k
Thomas Chittenden United States	11	1.8k 1.1×	1.5k 1.3×	525 0.5×	132 0.3×	328 1.3×	25	3.4k
Hovav Nechushtan Israel	31	1.5k 0.9×	955 0.8×	874 0.8×	186 0.5×	276 1.1×	117	3.0k

Countries citing papers authored by Hidetoshi Sumimoto

Since Specialization

Citations

This map shows the geographic impact of Hidetoshi Sumimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Sumimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Sumimoto more than expected).

Fields of papers citing papers by Hidetoshi Sumimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetoshi Sumimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Sumimoto. The network helps show where Hidetoshi Sumimoto may publish in the future.

Co-authorship network of co-authors of Hidetoshi Sumimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetoshi Sumimoto. A scholar is included among the top collaborators of Hidetoshi Sumimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetoshi Sumimoto. Hidetoshi Sumimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teramoto, Koji, Tomoyuki Igarashi, Yoko Kataoka, et al.. (2023). Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancer. Cancer Immunology Immunotherapy. 72(11). 3755–3764. 7 indexed citations

Sumimoto, Hidetoshi, Seiko Hattori, Chiaki Hasegawa, et al.. (2021). Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients. SHILAP Revista de lepidopterología. 2(1). 237–241. 4 indexed citations

Teramoto, Koji, Tomoyuki Igarashi, Yoko Kataoka, et al.. (2019). Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer. Lung Cancer. 137. 56–63. 49 indexed citations

Tanaka, Junichi, Yo Mabuchi, Kenji Hata, et al.. (2019). Sox9 regulates the luminal stem/progenitor cell properties of salivary glands. Experimental Cell Research. 382(1). 111449–111449. 16 indexed citations

Sumimoto, Hidetoshi, et al.. (2016). RAS-MAPK signaling is required for the enhanced PD-L1 expression in human lung cancers. Annals of Oncology. 27. vii85–vii86. 1 indexed citations

Sumimoto, Hidetoshi, Atsushi Takano, Koji Teramoto, & Yataro Daigo. (2016). RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers. PLoS ONE. 11(11). e0166626–e0166626. 142 indexed citations

Kawakami, Yutaka, Tomonori Yaguchi, Hidetoshi Sumimoto, et al.. (2013). Improvement of Cancer Immunotherapy by Combining Molecular Targeted Therapy. Frontiers in Oncology. 3. 136–136. 19 indexed citations

Higuchi, Hajime, Hidetoshi Sumimoto, Toru Igarashi, et al.. (2012). Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer. 16(1). 100–110. 54 indexed citations

Yaguchi, Tomonori, Hidetoshi Sumimoto, Chie Kudo‐Saito, et al.. (2011). The mechanisms of cancer immunoescape and development of overcoming strategies. International Journal of Hematology. 93(3). 294–300. 91 indexed citations

10.

Kido, Kenji, Hidetoshi Sumimoto, Sakiyo Asada, et al.. (2009). Simultaneous suppression of MITF and BRAF^V600E enhanced inhibition of melanoma cell proliferation. Cancer Science. 100(10). 1863–1869. 27 indexed citations

11.

Sumimoto, Hidetoshi & Yutaka Kawakami. (2009). The RNA Silencing Technology Applied by Lentiviral Vectors in Oncology. Methods in molecular biology. 614. 187–199. 8 indexed citations

12.

Tomita, Kengo, Yuichi Oike, Toshiaki Teratani, et al.. (2008). Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice†. Hepatology. 48(2). 458–473. 100 indexed citations

13.

Kawakami, Yutaka, Hidetoshi Sumimoto, Tomonobu Fujita, & Yuriko Matsuzaki. (2005). Immunological detection of altered signaling molecules involved in melanoma development. Cancer and Metastasis Reviews. 24(2). 357–366. 8 indexed citations

14.

Kawakami, Yutaka, Tomonobu Fujita, Yuriko Matsuzaki, et al.. (2004). Identification of human tumor antigens and its implications for diagnosis and treatment of cancer. Cancer Science. 95(10). 784–791. 53 indexed citations

15.

Kawakami, Yutaka, Xiang Wang, Tomoko Shofuda, et al.. (2001). Isolation of a New Melanoma Antigen, MART-2, Containing a Mutated Epitope Recognized by Autologous Tumor-Infiltrating T Lymphocytes. The Journal of Immunology. 166(4). 2871–2877. 51 indexed citations

16.

Nakazaki, Yukoh, Kazutoshi Tani, Hidetoshi Sumimoto, et al.. (1998). Vaccine effect of granulocyte–macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity. Gene Therapy. 5(10). 1355–1362. 32 indexed citations

17.

Kimura, Kazuhiro, Hiroshi Sakai, Hidetoshi Sumimoto, et al.. (1996). Leptomeningeal Carcinomatosis in Patients with Lung Cancer.. Haigan. 36(7). 879–883. 6 indexed citations

18.

Sumimoto, Hidetoshi, et al.. (1993). Primary Pulmonary Amyloidosis Mimicking Primary Lung Cancer. Journal of Computer Assisted Tomography. 17(5). 826–826. 6 indexed citations

19.

Takahashi, Kazuhide, Hidetoshi Sumimoto, Katsuo Suzuki, & Tetsuo Ono. (1993). Protein synthesis—dependent cytoplasmic translocation of p53 protein after serum stimulation of growth‐arrested MCF‐7 cells. Molecular Carcinogenesis. 8(1). 58–66. 35 indexed citations

20.

Toda, Katsumi, Takeshi Kawamoto, Hidetoshi Sumimoto, et al.. (1990). Structural and functional characterization of human aromatase P‐450 gene. European Journal of Biochemistry. 193(2). 559–565. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact